Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 May;2(3):103.
doi: 10.1200/JOP.2006.2.3.103.

Cost savings and luteinizing hormone-releasing hormone agonist

Steven Tucker

Cost savings and luteinizing hormone-releasing hormone agonist

Steven Tucker. J Oncol Pract. 2006 May.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Steven Tucker, MD
See this image and copyright information in PMC

References

    1. Wagmiller JA, Griggs JJ, Dick AW, et al: Individualized strategy for dosing luteinizing hormone–releasing hormone agonists for androgen-independent prostate cancer: Identification of outcomes and costs. J Oncol Pract 2:58-68, 2006 - PMC - PubMed
    1. Centers for Medicare & Medicaid Services: Payment allowance limits for Medicare Part B drugs. January 2006 ASP Pricing File. http://www.cms.hhs.gov/McrPartBDrugAvgSalesPrice/02_aspfiles.asp
    1. Small EJ, Klein EA: Challenges and future directions in the prevention and management of prostate cancer. J Clin Oncol 23:8143-8145, 2005
    1. Wang C, Catlin DH, Demers LM, et al: Measurement of total serum testosterone in adult men: Comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab 89:534-543, 2004 - PubMed
    1. Chen CD, Welsbie DS, Tran C, et al: Molecular determinants of resistance to antiandrogen therapy. Nat Med 10:33-39, 2004 - PubMed

LinkOut - more resources